This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: CLVS ENDP THC WRB


Clovis Oncology (CLVS) was upgraded at Piper Jaffray to overweight from neutral. $100 price target. Company offered positive CO-1686 data at ASCO, Piper Jaffray said.

Con-way (CNW) was upgraded at Bank of America to buy from underperform. $46 price target. The Freight segment is improving faster than expected, BofA said.

Citrix Systems (CTXS) was downgraded at Berenberg to sell. $49 price target. Legacy business could lag, Berenberg said.

Endo Health (ENDP - Get Report) was downgraded at Cantor Fitzgerald to sell from hold. $30 price target. Expect a prolonged restructuring period, Cantor said.

Endo Health was upgraded at Leerink Swann. $48 price target. Expectations have come down, and 2013 guidance is now achievable, Leerink Swann said.

First Horizon National (FHN) was downgraded at Morgan Stanley to equal weight. There is limited near-term upside as the stock has outperformed its peers since the first quarter of 2012, Morgan Stanley said.

Haemonetics (HAE) was initiated with a market outperform rating at JMP Securities. The company's leading market position will be bolstered by M&A, and significant margin expansion is expected ahead, JMP said. Price target is $52.

Lifepoint (LPNT) was upgraded at Credit Suisse to outperform from neutral. Nonurban hospitals are best positioned for health care reform, Credit Suisse said.

LRR Energy (LRE) was downgraded to sell at TheStreet Ratings.

Oracle (ORCL) was downgraded at Berenberg to sell. $28 price target. Company may lag the pace of innovation in the software sector, Berenberg said.

Realpage (RP) was downgraded to sell at TheStreet Ratings.

Tenet Healthcare (THC - Get Report) was upgraded at Deutsche Bank to buy. $55 price target. Stock is attractive, following the recent pullback, Deutsche Bank said.

VMWare (VMW) was downgraded at Berenberg to sell. $57 price target. Company may be left behind by new technology trends, Berenberg said.

WR Berkley (WRB - Get Report) was upgraded at Bank of America/Merrill Lynch to buy from neutral. $46 price target. Stock is attractive, following a 12% pullback, BofA/Merrill said.

Stock Comments / EPS Changes

Brown-Forman (BF.B) estimates were reduced at UBS. Lower volume and pricing increased, said UBS.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CLVS $73.44 0.00%
ENDP $90.04 0.00%
THC $49.95 0.00%
WRB $50.31 0.00%
AAPL $123.25 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs